World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
54
Citations
12077
World Ranking
2315
National Ranking
154

Thorsten Stiewe publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Thorsten Stiewe sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 164 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Thorsten Stiewe D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Thorsten Stiewe sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 54 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Thorsten Stiewe is affiliated with Philipp University of Marburg in Germany. Their research contributions span several interconnected fields in biology and medicine, with a particular focus on cancer and molecular biology.

The primary fields of study for Thorsten Stiewe include Biochemistry, Genetics and Molecular Biology, and Medicine. More specific subfields that define their work are Molecular Biology, Oncology, Cancer Research, Immunology, and Epidemiology.

Their research covers multiple main topics such as Epigenetics and DNA Methylation, RNA modifications and cancer, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, Genomics and Chromatin Dynamics, RNA Research and Splicing, and Cancer-related gene regulation.

Frequent publication venues for Stiewe's work illustrate a broad engagement with scientific communities focused on cancer and molecular biology. Key journals include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • Cancer Research
  • Nucleic Acids Research
  • Nature Communications

Some recent papers provide insight into the scientist's research directions and focus areas. These include:

  • "The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic" (2020, Nature)
  • "Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer" (2020, Science Advances)
  • "mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability" (2020, Nature Communications)
  • "Lactate induces metabolic and epigenetic reprogramming of pro-inflammatory Th17 cells" (2022, EMBO Reports)
  • "p53's Extended Reach: The Mutant p53 Secretome" (2020, Biomolecules)

The frequent co-authors collaborating with Thorsten Stiewe are:

  • Andrea Nist
  • Marco Mernberger
  • Florian Finkernagel
  • Michael Wanzel
  • Robert Liefke

Best Publications

  • SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells.

    Parysatis Sachs;Dong Ding;Philipp Bergmaier;Boris Lamp

  • Role of the p53-homologue p73 in E2F1-induced apoptosis.

    Thorsten Stiewe;Brigitte M. Pützer

  • The p53 family in differentiation and tumorigenesis.

    Thorsten Stiewe

  • The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes

    Maik Luu;Sabine Pautz;Sabine Pautz;Vanessa Kohl;Rajeev Singh

  • The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic

    Eliran Kadosh;Irit Snir-Alkalay;Avanthika Venkatachalam;Shahaf May

  • Transactivation-deficient ΔTA-p73 Inhibits p53 by Direct Competition for DNA Binding IMPLICATIONS FOR TUMORIGENESIS

    Thorsten Stiewe;Carmen C. Theseling;Brigitte M. Pützer

  • Transactivation-deficient ΔTA-p73 Acts as an Oncogene

    Thorsten Stiewe;Sonja Zimmermann;Andreja Frilling;Helmut Esche

  • Gene expression changes in response to E2F1 activation

    Jens Stanelle;Thorsten Stiewe;Carmen C. Theseling;Martin Peter

  • A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism

    Ariel Pribluda;Ela Elyada;Zoltan Wiener;Haya Hamza

  • Role of p73 in malignancy: tumor suppressor or oncogene?

    T Stiewe;B M Pützer

  • Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

    M Michaelis;F Rothweiler;S Barth;J Cinatl

  • Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma

    Gamal-André Banat;Aleksandra Tretyn;Soni Savai Pullamsetti;Jochen Wilhelm

  • p53 family members in myogenic differentiation and rhabdomyosarcoma development.

    Hakan Cam;Heidi Griesmann;Michaela Beitzinger;Lars Hofmann

  • Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer

    Poonam Sarode;Xiang Zheng;Georgia A. Giotopoulou;Andreas Weigert

  • Quantitative TP73 Transcript Analysis in Hepatocellular Carcinomas

    Thorsten Stiewe;Sebastian Tuve;Martin Peter;Andrea Tannapfel

  • DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis

    Katharina Schlereth;Rasa Beinoraviciute-Kellner;Marie K. Zeitlinger;Anne C. Bretz

  • mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability

    Niklas Gremke;Pierfrancesco Polo;Aaron Dort;Jean Schneikert

  • How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.

    Thorsten Stiewe;Tali E. Haran

  • MGA, L3MBTL2 and E2F6 determine genomic binding of the non-canonical Polycomb repressive complex PRC1.6

    Bastian Stielow;Florian Finkernagel;Thorsten Stiewe;Andrea Nist

  • A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome

    Silke Reinartz;Florian Finkernagel;Till Adhikary;Verena Rohnalter

Frequent Co-Authors

Rolf Müller
Rolf Müller Saarland University
Werner Seeger
Werner Seeger University of Giessen
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Martin Michaelis
Martin Michaelis University of Kent
Yinon Ben-Neriah
Yinon Ben-Neriah Hebrew University of Jerusalem
Michael Kracht
Michael Kracht University of Giessen
Klaus Schughart
Klaus Schughart Helmholtz Centre for Infection Research
Markus Sauer
Markus Sauer University of Würzburg
Jindrich Cinatl
Jindrich Cinatl Goethe University Frankfurt
Achim D. Gruber
Achim D. Gruber Freie Universität Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students with a background in Molecular Biology, there are several related online degrees and career options to consider. Many professionals pursue further studies in healthcare, education, or research, and online programs make advancing your career more flexible than ever.

If you're interested in a fast-track to clinical roles, direct entry msn online programs are available for non-nurses seeking an advanced degree. For those already licensed as RNs, comparing top rated online nursing schools wgu can help you select a reputable institution for further study.

Bridge programs like rn to bsn to msn online programs are ideal for registered nurses aiming to advance into leadership positions. Always consider enrolling in not for profit online colleges to ensure accreditation, affordability, and strong student outcomes. By exploring these pathways, you can tailor your educational journey to fit your passion for molecular biology and the health sciences.

Best Scientists Citing Thorsten Stiewe

Trending Scientists

Recently Published Articles